Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
18%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
AGNG
80
HOLDINGS
12%
ALSO IN CANC
CANC
50
HOLDINGS
20%
ALSO IN AGNG
SECTOR DRIFT (AGNG minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in AGNG |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 3.0% | 2.9% | 2.9% |
|
AMGEN INC | 2.8% | 2.4% | 2.4% |
|
BRISTOL-MYERS SQUIBB CO | 2.3% | 3.4% | 2.3% |
|
ELI LILLY & CO | 2.3% | 3.6% | 2.3% |
|
BEIGENE LTD. SPONSORED ADR | 2.2% | 3.0% | 2.2% |
AGNG Overweight Relative to CANC
 |
UCB SA | 3.6% |
|
WELLTOWER, INC. | 3.3% |
|
EDWARDS LIFESCIENCES CORP | 3.2% |
|
JOHNSON & JOHNSON | 3.1% |
|
BOSTON SCIENTIFIC CORP | 3.1% |
 |
MEDTRONIC PLC | 3.1% |
 |
ASTRAZENECA PLC-SPONS ADR | 3.1% |
|
STRYKER CORP | 3.0% |
 |
ROCHE HOLDING AG-BR | 2.8% |
|
ALCON, INC. | 2.7% |
AGNG Underweight Relative to CANC
|
BRIDGEBIO PHARMA, INC. | -5.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.9% |
|
REVOLUTION MEDICINES, INC. | -4.8% |
 |
MERUS N.V. | -4.5% |
|
ASTRAZENECA PLC | -4.3% |
|
SUMMIT THERAPEUTICS INC | -4.2% |
|
NOVARTIS AG | -4.2% |
 |
GENMAB A/S SPONSORED ADR | -3.8% |
|
ARCELLX, INC. | -3.3% |
|
NUVALENT, INC. CLASS A | -3.2% |